MD Medical Group Completes Acquisition of Leading Healthcare Network in the Samara Region
MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), Russia’s leading provider of private women’s and children’s healthcare, is pleased to announce that it has completed the acquisition of the IDK Medical Company, a network of women’s and children’s health clinics located in the Russian region of Samara (“IDK”).
The acquisition of 100% of the outstanding share capital of Vitanostra Ltd, operator of IDK, was for USD 16.1 million in cash. IDK will now be integrated into the Company, adopting the Mother & Child brand to form Mother & Child IDK Samara.
Prior to the deal completion, MD Medical received all required approvals, including approval from the Russian Federal Antimonopoly Service.
Commenting on the acquisition, Chairman of MD Medical Group, Dr Mark Kurtser said:
“We are pleased to be able to complete this acquisition, which we view as an important strategic step for the business. With IDK’s business model similar to our own, we anticipate a smooth and swift integration process. Going forward, we will continue to seek opportunities to roll out our established business model in attractive and high-growth regions throughout Russia.”
* * *
Forward-Looking Statements:
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.